Boston Therapeutics may price $3 million private placement of shares

Deal funds corporate purposes, inventory, marketing, clinical trials

By Devika Patel

Knoxville, Tenn., June 7 - Boston Therapeutics, Inc. plans a $3 million private placement of stock, according to an 8-K filed Thursday with the Securities and Exchange Commission. The deal is subject to market conditions.

Proceeds will be used for general corporate purposes, which may include inventory, marketing and clinical trials.

Boston Therapeutics is a health product development and marketing company based in Manchester, N.H.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.